ADS

Groups Push to Reverse FDA on Zohydro

By

February 26, 2014
Spread the love

(MedPage Today) — A coalition of several advocacy groups wants to reinforce a message sent to FDA by other key policymakers: rescind approval of the powerful painkiller Zohydro. …read more    

By